Orchard Rx Ltd. ORTX 深 滬
已收盤 01-24 16:00:00 美东时间
16.70
0.000
0.00%
華盛通- 最 高--
- 今 開--
- 成交量 0股
- 最 低 --
- 昨 收 16.70
- 總市值 3.80亿
- 52周最高 16.72
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 4.24
- 委 比 0.00%
- 總股本 2272.72万
- 歷史最高 216.40
- 量 比 0
- 振 幅 0.00%
- 歷史最低 3.601
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Kyowa Kirin’s rare disease therapy becomes world’s most expensive drug
Orchard Therapeutics (ORTX), recently acquired by Kyowa Kirin (OTCPK:KYKOY), has set its newly FDA-approved rare disease therapy Lenmeldy at a wholesale price of $4.25M on Wednesday, making one-time g...
2024-03-21 00:11
XORTX Reprices Warrants Issued in Connection With Previous Private Placements
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION I...
2024-03-11 19:00
Kyowa Kirin Completes Acquisition Of Orchard Therapeutics
The acquisition of all outstanding shares of Orchard Therapeutics by way of a Scheme of Arrangement procedure under the UK Companies Act 2006 was completed on January 24, 2024, and Orchard Therapeutics has become a
2024-01-24 18:34
XORTX Announces $2 Million Public Offering
NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICESOR FOR DISSEMINATION IN...
2024-01-15 08:00
Orchard Therapeutics Wins Swissmedic Approval for Libmeldy in Early-Onset Metachromatic Leukodystrophy (MLD)
Orchard Therapeutics (NASDAQ:ORTX), a global gene therapy leader, today announced the Swiss Agency for Therapeutic Products (Swissmedic) has approved Libmeldy® (atidarsagene autotemcel), a hematopoietic stem
2023-12-11 20:02
Orchard Therapeutics 凭借 MPS-IH 中的 OTL-203 获得美国食品药品管理局快速通道称号
Previously reported results from ongoing proof-of-concept study showed extensiv...
2023-11-30 08:00
Orchard Therapeutics: Q3 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q3 earnings results on Monday, ...
2023-11-13 20:15
ALERT: The M&A Class Action Firm Continues Investigating the Merger - ORTX, SRT, CHS, ICPT
NEW YORK, Oct. 23, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities...
2023-10-24 08:55
Why Knight-Swift Transportation Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket
Gainers XORTX Therapeutics Inc. (NASDAQ: XRTX) shares surged 95.5% to $0.6226 in pre-market trading after jumping 34% on Thursday.
2023-10-20 19:42
